Some considerations on AI adoption according to Jack Parker, who participated in one of the panels at the Barcelona Deep Tech Summit. #barcelonadeeptechsummit #deep tech #BDTS24
Is the EU ‘losing the pace’ in the adoption of AI? This was the question put to the panel at the Barcelona Deep Tech Summit last week Myself, Juan, Mercè, Josep and Sara discussed the systemic barriers and day-to-day challenges associated with adopting AI into healthcare. In summary, here are some key considerations for innovators, clinicians, investors and the wider community: 1) In the healthcare realm, safety is priority. Therefore, incremental solutions with strong clinical evidence are more likely to be adopted than solutions which disrupt current workflows entirely 2) Explainability in not optional. ‘Black boxes’ have never, and will never cut it in medicine. Rightly so. 3) Regulatory certification (CE, UKCA, FDA) is certainly a milestone, but each user/site will likely require proof that your solution performs reliably on the local population. Plan for local pilots. 4) It’s high time for EU (and UK) academic institutions to adopt a more progressive approach towards the commercialisation of Deep Tech. Conservative attitudes towards tech transfer are currently stifling innovation. By releasing the chokehold on spin-outs, we can unlock the full potential of groundbreaking research and drive economic growth. If we don’t, to paraphrase Josep Ll. Sanfeliu ‘Deep Tech will stay deep in the depths of university labs’ A genuine pleasure to experience the ecosystem in Barcelona (look out Finland!) Huge thanks to Tech Barcelona for your hospitality, I hope to see you all very soon #deeptech #AiInHealthcare #innovation AIATELLA
